← Eichor
Study identifier: NCT07396766 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Dissemination of BREASTChoice AIM1-B

Condition: Breast Cancer · Breast Neoplasms  ·  Sponsor: UNC Lineberger Comprehensive Cancer Center

PhaseNA
Planned participants20
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This registration covers only Aim 1b, which focuses on testing usability. The study will include 20 participants who are breast cancer patients. Participants will be observed using the tool on their mobile devices, and their experience will be evaluated using a "think-aloud" method to capture their thoughts and reactions. Interviews will include open-ended questions about the content and format of the decision aid, with follow-up prompts to gather feedback on design elements (length, order, graphics), comprehension, ease of use, acceptance, and engagement with the tool. Knowledge will be measured using the Decision Quality Instrument before and after using the tool. Results will be analyzed to develop recommendations for the final version of the tool.

This description comes directly from the study's public registry record.

Talk to the study team

Victoria Triana  ·  919-966-4320  ·  Victoria_Triana@med.unc.edu

Kathryn A Chetwynd  ·  919-966-4320  ·  Kathryn_Chetwynd@med.unc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

The University of North CarolinaChapel Hill, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07396766